Skip to main content

Year: 2026

Pharming Group announces the filing of its 2025 Annual Report and Form 20-F

Leiden, the Netherlands, April 2, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) today announced the filing of its Annual Report for the year ended December 31, 2025. The Annual Report is available at annualreport.pharming.com and under Investors/Financial documents on the Pharming.com website. The Company also announced the filing of its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission (SEC). The 2025 Annual Report on Form 20-F can be found under Investors/SEC filings on Pharming.com and through the SEC website once it has been filed. About Pharming Group N.V. Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases....

Continue reading

Cerrado Gold Announces Q4 and Annual 2025 Financial Results

Annual Production for 2025 of 50,238 Gold Equivalent Ounces (“GEO”); and AISC of US$1,746 per ounce, in line with guidance 2026 Production guidance of 50,000 to 60,000 GEO weighted to H2/26 Adjusted EBITDA of $22.3 million for Q4, and $46.1 million for the full year Completed hedging program provides full future leverage to high gold prices Exited the year with a strong cash position of over $22 million Management to host Conference Call to discuss the financial and operational results on [April 2nd, 2025, at 11:00 AM EDT]TORONTO, April 02, 2026 (GLOBE NEWSWIRE) — Cerrado Gold Inc. [TSX.V:CERT][OTCQX:CRDOF; FRA:BAI0] (“Cerrado” or the “Company”) announces its operational and financial results for the fourth quarter (“Q4/25”), including its Minera Don Nicolas (“MDN”) gold project in Santa Cruz Province, Argentina, the highly...

Continue reading

Millicom prices reopening of $75 million of 7.375% Senior Notes Due 2032

Millicom prices reopening of $75 million of 7.375% Senior Notes Due 2032 Luxembourg, April 2, 2026 – Millicom International Cellular S.A. (“Millicom”) (NASDAQ US, TIGO) announces today the successful pricing of $75 million aggregate principal amount of its 7.375% Senior Notes due 2032 (the “Additional Notes”) in a Regulation S only tap private placement to an investor that is not a “U.S. Person” (as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”)) at a price of 100.985%, plus accrued and unpaid interest from and including April 2, 2026 to, but excluding, the issue date of the Additional Notes. The Additional Notes will be issued as a reopening of, and will be part of the same series as, the 7.375% Senior Notes due 2032 that Millicom originally issued on April 2, 2024 (the “Initial Notes”...

Continue reading

Celldex Announces Pricing of $300 Million Public Offering of Common Stock

HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 10,345,000 shares of its common stock at a public offering price of $29.00 per share. All of the shares to be sold in the offering are to be sold by Celldex. In connection with the offering, Celldex has also granted the underwriters a 30-day option to purchase up to an additional 1,551,750 shares of common stock at the public offering price, less the underwriting discounts and commissions. The Company expects to receive gross proceeds from the offering, excluding the exercise of the underwriters’ option, if any, of approximately $300 million, excluding the underwriting discounts and commissions and other offering-related expenses. The offering is...

Continue reading

Trisura Group Announces Changes to Its Board of Directors

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced the appointment of Chris Sekine to its Board of Directors and the retirement of Robert Taylor. In addition, Trisura today announced that Chris Sekine is expected to stand for election to the Board of Directors at this year’s Annual Meeting of Shareholders. Mr. Taylor served as the Chairman and a director of Trisura Guarantee Insurance Company from 2013 to 2017. As a co-founder of Trisura Guarantee Insurance Company, Mr. Taylor served as the CEO of the company from its inception in 2006 until 2012. Mr. Sekine served as President and CEO of Trisura Guarantee Insurance Company from 2018 to 2024 and has been with the Company since its inception in 2006 when he established the...

Continue reading

Telix Appoints David Gill as Non-Executive Director

MELBOURNE, Australia and INDIANAPOLIS, April 02, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the appointment of David Gill as a Non-Executive Director (NED), as part of Board expansion and succession planning. The appointment is effective May 11, 20261. Mr. Gill is expected to be appointed as Chair in due course, succeeding Dr. Mark Nelson who will remain on the Board as a NED. Mr. Gill is a life sciences executive with over 35 years’ experience in senior general management and financial leadership roles across commercial and clinical-stage biopharmaceutical (including radiopharmaceuticals) and medical device companies. He currently serves on the boards of Evolus, Inc. (NASDAQ: EOLS), Allucent LLC, Bridge to Life Ltd, RapidPulse Inc. and huMannity Medtec (formerly Alfred...

Continue reading

JD.com Announces Pricing of CNY10 Billion CNY-denominated Senior Notes

BEIJING, April 01, 2026 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the “Company” or “JD.com”), a leading supply chain-based technology and service provider, today announced the pricing of its offering of CNY10 billion aggregate principal amount of CNY-denominated senior unsecured notes (the “Notes”). The Notes were offered in offshore transactions outside the United States to certain non-U.S. persons (the “Notes Offering”) in reliance on Regulation S under the United States Securities Act of 1933, as amended (the “Securities Act”). The Notes Offering consists of CNY7.5 billion of 2.05% notes due 2031 and CNY2.5 billion of 2.75% notes due 2036. The Company expects to close the Notes Offering on or about April 10, 2026, subject to the satisfaction of customary closing conditions. The...

Continue reading

Abaxx Submits Comments to the National Institute of Standards and Technology on AI Agent Identity Standards

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte. Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that it has submitted technical comments to the National Institute of Standards and Technology (“NIST”) in response to its request for input related to a project on identity and authorization for software and artificial intelligence (“AI”) agents. In February 2026, the NIST National Cybersecurity Center of Excellence (NCCoE) released a concept paper outlining considerations for a potential project to demonstrate how identity standards and best practices can be applied to software and...

Continue reading

Westport Announces Issuance of Management Cease Trade Order

VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport” or the “Company”) (TSX:WPRT / Nasdaq: WPRT) today announced that the British Columbia Securities Commission, the Company’s principal regulator, has issued a temporary management cease trade order (the “MCTO“) against the Company under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“). The MCTO restricts trading in the Company’s securities by the CEO and CFO, but does not restrict trading by other shareholders or investors. “On March 20, 2026, we announced that we had recently identified unauthorized access to certain internal systems and acted immediately to contain the incident, engaging cybersecurity experts and strengthening our safeguards,” said Dan Sceli, Chief Executive Officer of Westport. “Importantly,...

Continue reading

Mannatech Announces Notification of Late Filing

FLOWER MOUND, Texas, April 01, 2026 (GLOBE NEWSWIRE) — Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech” or “the Company”) announced today that it has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission with regard to its annual report on Form 10-K (the “2025 Form 10-K”) for the fiscal year ended December 31, 2025. Form 12b-25 allows the Company an automatic extension of 15 additional calendar days to file the 2025 Form 10-K, which is due on March 31, 2026. The Company expects to file the 2025 Form 10-K as soon as practicable by April 15, 2026, in accordance with Rule 12b-25. The 12b-25 filing is available on the Company’s website under ir.Mannatech.com. About Mannatech:Mannatech is a leading global health and wellness company committed to empowering everyone to live their best life...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.